Form 4/A for ALLO Allogene Therapeutics, Inc.
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-14 · accession 0001214659-22-004729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MAI | 2022-04-01 | 2022-03-14 | ALLO | Belldegrun Arie | Dir | J - Other | $0.00 | 0 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | J | A | 4,710,120 | $0.00 | 4,710,120 | I See footnote | — | — | (F1) This amendment is being filed to correct the share holdings reported on the Form 4 filed by the reporting person on March 31, 2022. (F2) These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00. |
| 2 | Common | Common Stock | 2022-03-14 | J | D | 4,710,120 | $0.00 | 0 | I See footnote | — | — | (F2) These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00. |